SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 16.83 |
Enterprise Value ($M) | -1.26 |
Book Value ($M) | 19.06 |
Book Value / Share | 0.54 |
Price / Book | 0.88 |
NCAV ($M) | 18.43 |
NCAV / Share | 0.52 |
Price / NCAV | 0.91 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.41 |
Return on Assets (ROA) | -0.19 |
Return on Equity (ROE) | -0.38 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.93 |
Current Ratio | 3.93 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 24.98 |
Assets | 25.60 |
Liabilities | 6.54 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 41.09 |
Operating Income | -8.27 |
Net Income | -8.07 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -19.03 |
Cash from Investing | 13.81 |
Cash from Financing | 0.16 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Decheng Capital Management IV (Cayman), LLC | 15.60 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
33,960 | 44,451 | 76.40 | |
20,098 | 71,793 | 27.99 | |
22,978 | 71,476 | 32.15 | |
(click for more detail) |
Similar Companies | |
---|---|
ENTX – Entera Bio Ltd. | ENVB – Enveric Biosciences, Inc. |
EPIX – ESSA Pharma Inc. | ERNA – Ernexa Therapeutics Inc. |
ESLA – Estrella Immunopharma, Inc. |
Financial data and stock pages provided by
Fintel.io